TW207541B - - Google Patents

Info

Publication number
TW207541B
TW207541B TW081107187A TW81107187A TW207541B TW 207541 B TW207541 B TW 207541B TW 081107187 A TW081107187 A TW 081107187A TW 81107187 A TW81107187 A TW 81107187A TW 207541 B TW207541 B TW 207541B
Authority
TW
Taiwan
Prior art keywords
lower alkyl
cycloalkyl
alkyl group
optionally substituted
denotes hydrogen
Prior art date
Application number
TW081107187A
Other languages
English (en)
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Application granted granted Critical
Publication of TW207541B publication Critical patent/TW207541B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
TW081107187A 1991-07-31 1992-09-10 TW207541B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125292A DE4125292A1 (de) 1991-07-31 1991-07-31 6-oxo-azepinoindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
TW207541B true TW207541B (zh) 1993-06-11

Family

ID=6437366

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081107187A TW207541B (zh) 1991-07-31 1992-09-10

Country Status (21)

Country Link
US (1) US5272143A (zh)
EP (1) EP0525584B1 (zh)
JP (1) JP3174158B2 (zh)
KR (1) KR930002353A (zh)
CN (2) CN1069733A (zh)
AT (1) ATE161012T1 (zh)
AU (1) AU649153B2 (zh)
CA (1) CA2075102A1 (zh)
CZ (1) CZ239392A3 (zh)
DE (2) DE4125292A1 (zh)
ES (1) ES2110454T3 (zh)
FI (1) FI923440A (zh)
HU (2) HU211105B (zh)
IE (1) IE922310A1 (zh)
IL (1) IL102503A (zh)
MX (1) MX9204457A (zh)
NO (1) NO300375B1 (zh)
NZ (1) NZ243715A (zh)
RU (1) RU2078765C1 (zh)
TW (1) TW207541B (zh)
ZA (1) ZA925093B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414130A (en) * 1993-12-23 1995-05-09 The Dow Chemical Company Process for the preparation of diaminoresorcinol
AP1538A (en) * 1999-01-11 2006-01-10 Agouron Pharma Tricyclic inhibitors of poly (adp-ribose) polymerases.
ECSP003637A (es) 1999-08-31 2002-03-25 Agouron Pharma Inhibidores triciclicos de poli (adp-ribosa) polimerasas
MX2010012807A (es) * 2008-05-29 2010-12-21 Albany Molecular Res Inc Moduladores del rceptor 5-hidroxitriptamina 3, metodos de fabricacion y uso de los mismos.
PT3150610T (pt) * 2010-02-12 2019-11-11 Pfizer Sais e polrmorfos de 8-fluor0-2-{4- [(metilamino}metil]fenil}-1,3,4,5-tetrahidr0-6hazepin0[ 5,4,3-cd]indol-6-0na
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
US11236103B2 (en) 2018-07-27 2022-02-01 Biotheryx, Inc. Bifunctional compounds
EP4143329A4 (en) 2020-04-28 2024-10-16 Anwita Biosciences Inc INTERLEUKIN-2 POLYPEPTIDES AND FUSION PROTEINS THEREOF, AS WELL AS THEIR PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
CA2075102A1 (en) 1993-02-01
EP0525584A1 (de) 1993-02-03
US5272143A (en) 1993-12-21
NO300375B1 (no) 1997-05-20
DE59209055D1 (de) 1998-01-22
IE922310A1 (en) 1993-02-10
KR930002353A (ko) 1993-02-23
JP3174158B2 (ja) 2001-06-11
ES2110454T3 (es) 1998-02-16
HU210217A9 (en) 1995-02-28
HU211105B (en) 1995-10-30
HUT65453A (en) 1994-06-28
NO923004L (no) 1993-02-01
RU2078765C1 (ru) 1997-05-10
MX9204457A (es) 1993-05-01
DE4125292A1 (de) 1993-02-04
FI923440A0 (fi) 1992-07-30
CN1069733A (zh) 1993-03-10
JPH05202052A (ja) 1993-08-10
IL102503A0 (en) 1993-01-14
ATE161012T1 (de) 1997-12-15
EP0525584B1 (de) 1997-12-10
FI923440A (fi) 1993-02-01
HU9202430D0 (en) 1992-10-28
AU2067792A (en) 1993-02-04
CN1141773A (zh) 1997-02-05
CZ239392A3 (en) 1993-04-14
NZ243715A (en) 1995-03-28
AU649153B2 (en) 1994-05-12
NO923004D0 (no) 1992-07-30
ZA925093B (en) 1993-04-28
IL102503A (en) 1995-12-31

Similar Documents

Publication Publication Date Title
CY2069B1 (en) Xanthine compounds
PL263885A1 (en) Method of obtaining novel derivatives of dihydrobenzofurane and chromate carbonamide
TW207541B (zh)
ES8607218A1 (es) Un procedimiento para preparar compuestos de amidina
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
ES8601201A1 (es) Procedimiento para preparar derivados de imidazolina
DE69002474D1 (en) Carboxyalkyl-ether von 2-amino-7-hydroxytetralin.
JPS6440479A (en) Piperidine derivative
TW225989B (zh)
TW334428B (en) Novel benzodiazepine derivatives
NO855383L (no) Fremgangsmaate for fremstilling av piperazin-derivater.
ZA898342B (en) Substituted 3-aminosydnonimines,processes for their preparation and their use
ES477709A1 (es) Procedimiento de preparacion de nuevos compuestos cis- y trans-1,5-benzotiacepinicos.
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents